Abstract
Introduction

48
Zika virus (ZIKV), an enveloped positive-strand RNA virus of the family 49 Flaviviridae, has recently emerged as a significant global human health threat 1 . 50 Following its rapid expansion into the Americas, ZIKV was found to possess a unique 51 combination of virulence traits, including the ability to cross the human placental barrier 52 and cause microcephaly and other congenital abnormalities . The resulting disruption of cellular networks can directly contribute to clinical 55 disease, raising the need for systems biology methods to elucidate host-virus 56 interactions within and between all host tissue compartments 5, 6 . 57 The development of genome-scale CRISPR/Cas9 knockout screens has 58 tremendously advanced investigations into genetic factors that affect disease . These steps appear 79 to require a specific lipid milieu, as flaviviruses presumably modify various host lipid 80 pathways to create this milieu [14] [15] [16] . A rapidly growing body of knowledge on the 81 importance of lipids in cell organization, signaling networks, and viral disease outcomes 82 therefore led us to investigate how ZIKV perturbs cellular lipid metabolic networks to 83 establish and promote infection 17, 18 . 84 To systematically map the host lipid-virus interaction networks in an unbiased 85 manner, we carried out a global lipidomic survey in ZIKV-infected human cells. We also 86 performed similar lipidomic profiling in cells that ectopically express NS4B, one of the 87 non-structural proteins of ZIKV known to be involved in forming viral replication sites 19 . 88 We found that ZIKV infection as well as NS4B expression significantly alters the lipid 89 composition of human cells, with the most striking pattern of changes seen within 90 sphingolipids. Ceramide, a bioactive sphingolipid implicated in signaling and apoptosis, 91 is recruited to ZIKV replication sites and strongly associate with the ZIKV non-structural 92 protein NS4B. We used pharmacological inhibition and genetic knockouts of enzymes First, NS4B is a transmembrane protein that produces the strongest ER stress and autophagic 156 response of the ten flavivirus proteins when individually expressed 26, 27 , and lipid metabolism is 157 coordinately regulated with these pathways during periods of stress [28] [29] [30] [31] . To examine whether ZIKV NS4B could similarly regulate global lipid metabolism, we 164 performed a second lipidomic survey of HEK293T cells transfected with ZIKV NS4B-FLAG or an 165 empty vector control ( Fig. 2a and Supplementary Fig. 3a-d) . Supporting its role as a major factor 166 in host-virus interactions, NS4B caused significant down-or up-regulation (P < 0.05, one-way 167 ANOVA) in 44% of the 318 lipid species identified relative to the control (Fig. 2b and  168 Supplementary Data 2). Furthermore, many of these changes were comparable to or exceeded 169 those of similar species in ZIKV-infected cells, especially in the negative direction (Fig. 2c) . 170
We analyzed the relationship between NS4B transfection and ZIKV infection for the set 171 of lipid species (n = 98) that appeared in both datasets and found a weak but highly statistically 172 significant positive correlation between the two conditions (P < 0.05, Pearson correlation 173 coefficient) (Fig. 2d) . Strikingly, ceramides were the only species that were significantly enriched 174 by over a log in both conditions (Fig. 2d) . When we repeated our analysis for individual lipid 175 classes, sphingolipids were even more strongly correlated than total lipids, or phospholipids and 176 glycerolipids alone (Fig. 2e) . Together, our results support a causal relationship between NS4B 177 expression and targeted regulation of sphingolipid metabolism, along with previously described 178 stress-signaling pathways. 179
180
Depletion of cellular sphingolipids inhibits ZIKV propagation 181
De novo sphingolipid biosynthesis begins in the ER with the condensation of L-serine 182 and palmitoyl CoA catalyzed by serine palmitoyltransferase (SPT) (Fig. 3a) . Further reactions 183 yield dihydrosphingosine, which is converted by ceramide synthase (CerS) to dihydroceramide, 184 then to ceramide (Cer), the precursor to SM and other downstream sphingolipids. To determine 185 if ZIKV could replicate in the absence of sphingolipids, we used the small-molecule inhibitors 186 myriocin and fumonisin B1 (FB1) to block the activity of SPT and CerS, respectively (Fig. 3a) . Fig. 4c-f) , while cell growth rate and morphology was not affected 191 ( Supplementary Fig. 5a, b) . 192
Next, we examined the ability of ZIKV to propagate in inhibitor-treated cells. Huh7 cells 193 treated with myriocin or FB1 and infected at an MOI of 0.1 showed a 30-fold reduction in 194 infectious virions released into the culture supernatant 24 hours after infection, a difference that 195 increased to over 100-fold after 72 hours (Fig. 3b) . To control for the possibility that the 196 inhibitors reduced ZIKV particle infectivity, we performed RT-qPCR to quantify the number of 197 ZIKV genomes released into the supernatant of treated and untreated Huh7 cells (Fig. 3c) . . 221
Therefore, we decided to use iPSC-derived NPCs to validate our key findings by manipulating 222 sphingolipid levels in these cells using myriocin and FB1. Inhibitor-treated cells showed a 223 significantly reduced level of viral shading as compared to untreated cells, showing roles for 224 sphingolipids in ZIKV infection in neuronal primary cells (Fig. 3g) . In addition to iPSC-derived 225 NPCs, we also employed the human neuroblastoma cell line SH-SY5Y to validate our initial 226 findings further. Consistent with the Huh7 and NPCs, both myriocin and FB1 significantly 227 reduces the amount of ZIKV production (Fig. 3h) (Fig. 4b) . After the initiation of RNA replication by 3-4 hpi, levels of RNA in 246 sphingolipid-depleted cells more than 60% relative to vehicle-treated cells, and remained over 247 30% lower by 20 hpi (Fig. 4b) . To confirm that these differences were due to decreased RNA 248 replication rather than defects at other stages of the viral life cycle, we treated infected 249 sphingolipid-depleted and normal cells with an inhibitor of ZIKV RNA polymerase (TPB) 49 and 250 measured intracellular replication relative to non-TPB-treated cells at 8 hpi ( we tested RFECV-identified ratios that fell above the stringent cutoffs of component score > 0.1 275 and F-score > 50. This yielded four Cer/Cer ratios (P < 0.01, one-way ANOVA) ( Fig. 5d-g ); 276
Strikingly, each of these high-interest ratios contained the (dihydro)ceramide Cer(d18:0/16:0) or 277 Cer(d18:1/16:0), which was the single most enriched lipid by both ZIKV and NS4B (Fig. 2d) . 278
Recently, it has been shown that the six mammalian ceramide synthases (CERS1-6) 279 preferentially catalyze the formation of ceramide species with different acyl chain lengths and 280 degrees of saturation 51, 52 , and that the signaling properties of ceramides are influenced by acyl-281 chain identity 53 . Our data indicates that ZIKV infection, and NS4B expression, increases the 282 production of Cer(d18:1/16:0) relative to other ceramide species. 283
Three major pathways control ceramide levels in mammalian cells: (1) de novo synthesis 284 in the ER, (2) degradation of SM by a family of sphingomyelinases (SMases), and (3) salvage of 285 sphingolipid catabolism products via conversion to sphingosine (Fig. 5a ). Because SM is the 286 most abundant sphingolipid in mammalian cells and represents a major outlet for newly 287 synthesized ceramides, we reasoned that flux between SM and Cer likely contributed to ZIKV-288 driven increases in Cer/SM ratios. To test this hypothesis, we infected KBM7 cells bearing a 289 gene-trap mutation for SGMS1, the major human sphingomyelin synthase 54, 55 . KBM7 SGMS1 . The 308 physical interactions between lipids, proteins, and other macromolecules are increasingly the 309 focus of efforts to systematically map the biological networks underlying disease 60, 61 . These 310 maps have provided evidence that disorders which are unrelated in origin but similar in 311 phenotype can share overlapping patterns of genetic and metabolic perturbations, forming 312 distinct disease modules within the human interactome [62] [63] [64] . 313
Having shown the importance of the sphingolipid network in ZIKV replication, we asked if 314 it interacted with known disease modules that were clinically similar to the symptoms of ZIKV 315 infection. To accomplish this, we built a metabolic network containing the biosynthesis pathways 316 of each subclass in our lipidomics dataset ( Supplementary Fig. 8a ) then surveyed the network 317 14 for metabolites associated with seven Medical Subject Heading (MeSH) terms selected for their 318 similarity to clinical outcomes of ZIKV infection [65] [66] [67] . As a consequence of including all 319 compounds and genes from the constituent lipid biosynthesis pathways in our metabolic model 320 (Supplementary Data 5), nearly every node of the resulting disease-metabolite network was a 321 non-lipid compound capable of participating in other aspects of cellular metabolism (Fig. 6e) . 322
Remarkably, however, the two network nodes with the greatest number of connections to MeSH 323 disease terms were the sphingosine and sphinganine, which differ by only a single double bond 324 (Fig. 6f) . In addition to forming the sphingoid bases incorporated into all other sphingolipids, 325 sphinganine and sphingosine are immediate neighbors of SM and Cer, with which they can be 326 readily interconverted (Fig. 6f and Fig. 5a ). 327 328
Ceramide is redistributed to ZIKV replication membranes 329
The set of network perturbations we defined left open the function of ceramide's role 330 during ZIKV replication. Our results suggested that the defects in production of new ZIKV RNA 331 and proteins in the replication factory ( Fig. 3d and Fig. 4b, c) , rather than their assembly or 332 maturation ( Fig. 3c and Fig. 4a ), caused reduced viral shedding from sphingolipid-depleted 333 cells, leading us to hypothesize that ceramide was physically recruited to membranes of the 334 ZIKV replication site. Providing a remarkable link to our lipidomics results, superresolution 335 microscopy revealed a close association between ceramide and replication complex marker 336 NS4B (Fig. 7a, g ). As a control, we also measured overlap between ceramide and E protein, 337 which is produced at replication sites but not thought to be present in replication vesicles; further 338 supporting a specific function for ceramide in replication vesicles, we observed no correlation 339 with E protein (Fig. 7b, g . We did not observe correlation between Eqt-SM-347 GFP and NS4B or E (Fig. 7c, d and g ). This did not prevent enrichment of ceramide in the ER 348 during ZIKV infection (Fig. 7e, f and , and that minor changes in genome sequence can greatly affect ZIKV 388 infectivity and virulence [76] [77] [78] . We show here that ectopic expression of ZIKV NS4B, a 389 transmembrane protein integral to the Flaviviridae replication complex The biosynthesis, degradation, and intracellular distribution of ceramides is tightly 397 controlled through a complex regulatory circuit [79] [80] [81] [82] [83] [84] , including glycosylation to form complex 398 sphingolipids or conversion to the highly abundant sphingomyelin 85 . We observed increasing 399 ratios of ceramide to sphingomyelin over the course of infection, essentially reversing 400 homeostatic trends in both lipids. To test this experimentally, we infected a KBM7 cell line 401 containing an inactivating mutation for SGMS1, the enzyme responsible for most SM synthesis 402 in mammalian cells 54, 86 , and observed significant enhancement of ZIKV infection in SGMS1 Indeed, the role of sphingolipid signaling in regulating cell death, including during neural 418 development, has been extensively described [91] [92] [93] . 
Methods
425
Cell culture and transfections 426
Huh7, Vero, and HEK 293T cells were maintained in DMEM; HAP1 cells and KBM7 cells were 427 maintained in IMDM. Both media contained 10% FBS, 100 units/mL penicillin, 100 µg/mL 428 streptomycin, and 1% non-essential amino acids. C6/36 cells were maintained in MEM 429 containing 5% FBS, 100 units/mL penicillin, 100 µg/mL streptomycin, and 1% non-essential 430 amino acids. Mammalian cell lines were maintained at 37°C and 5% CO2; C6/36 cells were 431 maintained at 32°C and 5% CO2. ; none failed to meet these requirements and thus all lipids were 511 retained for further analysis. The data were normalized using global median centering, in which 512 each sample was scaled by the median of its observed abundance values. This approach has 513 been described previously [104] [105] [106] [107] and utilized in a number of other studies [108] [109] [110] . Lipids were 514 evaluated using analysis of variance (ANOVA) with a Dunnett test correction to compare 515 infected to mock at each timepoint (24 hours and 48 hpi). Yellowbrick 111 was used to perform 516 recursive feature extraction. 517 518
Cell culture treatments 519
Myriocin, FB1, and GW4869 were purchased from Cayman Chemical. Myriocin was dissolved in 520 DMSO to make 15 mM stock solutions, and added to culture media at 1:500 for a final 521 concentration of 30 µM; because myriocin is not fully soluble at 15 mM, stocks were thawed at 522 room temperature, then heated for 15 min at 55°C immediately before addition to media. FB1 523 was dissolved in 1:1 acetonitrile:DI water to make 5 mM stocks, then added 1:1,000 to culture 524 media for a final concentration of 5 µM. Myriocin and FB1 treatments were carried out for 72 hrs 525 before experimental manipulations; we did not observe significant differences in growth rate or 526 morphology over that period (Supplementary Fig. 2 ). GW4869 was added to culture media for 527 23 24 hrs at a final concentration of 10 µM, and stocks were prepared as previously outlined 112 . No 528 significant toxicity was observed by CellTiter Glo assay (Promega) (Supplementary Fig. 4 ). All 529 inhibitor stocks were stored at -20°C. Neutral sphingomyelinase from Bacillus cereus (Sigma-530 Aldrich) was supplied at 2.5 units/mL (one unit is defined as hydrolyzing 1 μM of TNPAL-531 sphingomyelin per min at pH 7.4 and 37°C) in 50% glycerol containing 50 mM Tris-HCl, pH 7.5. 532
SMase was diluted in culture media to a final concentration of 0.1 units/mL and added to cells 533 immediately after infection with ZIKV before supernatants were collected for titration by plaque 534 assay at 24 hpi. PBS to remove extracellular virus and lysed with 1% SDS in PBS, followed by three rounds of 585 heating (95°C for 5 min) and manual vortexing to complete lysis. Protein levels were determined 586 on a NanoDrop spectrophotometer (Thermo Fisher Scientific); equal amounts of protein were 587 subjected to SDS-PAGE and transferred to a PVDF membrane (Amersham). Samples blocked 588 with 5% dried milk in TBST and probed with monoclonal antibodies for flavivirus E protein (4G2) 589
(1:500) and GAPDH (1:1,000), followed by incubation for 1 hr with HRP-conjugated secondary 590 antibodies (1:1,000). Blots were visualized with SuperSignal West Pico chemiluminescent 591 substrate (Thermo Fisher Scientific) on an ImageQuant LAS 4000 imager (GE Life Sciences). 592
593
Binding and entry assay 594
Vero cells were seeded in six-well plates at approximately 250,000 cells per well so they were 595 80-90% confluent the next day. These monolayers were washed three times with ice-cold PBS 596 to inhibit endocytosis, and inoculated with 100 PFUs of ZIKV diluted in ice-cold Opti-MEM 597 containing 2% FBS (0.5 mL inoculum per well). Cells and virus were incubated at 4°C with 598 rocking. After 0, 10, 20, and 45 minutes, the inoculums were aspirated and the cell layers 599 washed three times with ice-cold PBS before addition of Opti-MEM containing 2% FBS and 1% 600 methylcellulose. Plates were incubated for three days at 37°C and 5% CO2. After that period, 601 the overlay media was removed through repeated PBS washes, and the cells were fixed with 602 4% paraformaldehyde and stained as for plaque assays as described above. Analysis of lipidomics datasets was performed as described above. All other statistical analyses 630 were performed using Prism 8.0 (GraphPad). Unless otherwise stated, hypothesis testing was 631 performed using unpaired two-tail t tests, with P < 0.05 considered statistically significant. 632
633
Data availability 634
All mass spectrometry datasets generated during this study have been deposited at the Mass 635 ) were pretreated for 24 hrs with the RNA polymerase inhibitor TPB, infected as before, then maintained in TPB and inhibitor/vehicle treated media for 8 hrs. At 8 hpi, intracellular replication in TPB-treated cells was measured relative to non-TPB-treated cells for each condition. Data are mean ± SD; n.s., not significant, *P < 0.05, **P < 0.01, ***P < 0.001, two-tailed Student's t-test. See also the Source Data file. 
